← Back to Search

Psychedelic

Psilocybin for Post-Traumatic Stress Disorder

Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center, Columbus, OH
Targeting 5 different conditionsPsilocybinPhase 2RecruitingLed by Alan K Davis, PhDResearch Sponsored by Ohio State University

Study Summary

This trial will test whether psilocybin can help treat PTSD in military veterans.

Eligible Conditions
  • Post Traumatic Stress Disorder
  • Trauma and Stressor Related Disorders
  • Psychiatric Disorder
  • Post-Traumatic Stress Disorder
  • Traumatic Stress Disorders

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
Select...
You have only used hallucinogenic drugs a few times in your life.
Select...
You have a score of 35 or higher on a test that measures the severity of your symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to primary endpoint (1 month post psilocybin session 2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to primary endpoint (1 month post psilocybin session 2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Columbia Suicide Severity Rating Scale (C-SSRS)
Therapy, Computer-Assisted
Secondary outcome measures
Post-Traumatic Stress Disorder
PTSD Symptom Severity as measured by the Clinician Administered PTSD Scale-5 (CAPS-5)

Side effects data

From 2021 Phase 2 trial • 95 Patients • NCT02061293
44%
Headache
21%
Nausea
15%
Anxiety
8%
Suicidal Ideation
6%
Insomnia
6%
Depressed mood
4%
Abdominal pain upper
4%
Vomiting
4%
Corona virus infection
4%
Upper respiratory tract infection
4%
Viral upper resp. tract infection
4%
Alcohol poisoning
4%
Depression
4%
Pneumonia
2%
Illusion
2%
Urinary incontinence
2%
Biopsy cervix
2%
Palpitations
2%
Cataract
2%
Abdominal pain
2%
Toothache
2%
Pain
2%
Limb injury
2%
Muscle strain
2%
Blood pressure diastolic increased
2%
Blood pressure increased
2%
Back pain
2%
Musculoskeletal pain
2%
Myalgia
2%
Dizziness
2%
Psychomotor hyperactivity
2%
Alcohol withdrawal syndrome
2%
Dysphoria
2%
Testicular pain
2%
Hyperventilation
2%
Food poisoning
2%
Food allergy
2%
Dyspepsia
2%
Influenza
2%
Nasal congestion
2%
Skin cosmetic procedure
2%
Photopsia
2%
Diverticulitis
2%
Asthenia
2%
Fatigue
2%
Gingivitis
2%
Dyspnea
2%
Oropharyngeal pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Psilocybin
Diphenhydramine

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Psilocybin-assisted therapyExperimental Treatment1 Intervention
Participants will receive two doses of psilocybin, approximately 2 weeks apart, in conjunction with preparatory and post-psilocybin therapy sessions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Psilocybin
2021
Completed Phase 2
~720

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
794 Previous Clinical Trials
459,690 Total Patients Enrolled
Alan K Davis, PhDPrincipal InvestigatorOhio State University

Media Library

Psilocybin (Psychedelic) Clinical Trial Eligibility Overview. Trial Name: NCT05554094 — Phase 2
Post-Traumatic Stress Disorder Research Study Groups: Psilocybin-assisted therapy
Post-Traumatic Stress Disorder Clinical Trial 2023: Psilocybin Highlights & Side Effects. Trial Name: NCT05554094 — Phase 2
Psilocybin (Psychedelic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05554094 — Phase 2
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT05554094 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this clinical study confined to individuals aged 75 and under?

"Prospective participants of this trial must be between the ages 21 and 64. For those younger or elder, there are 365 trials available to minors and 1033 options that cater to patients above the age of 65."

Answered by AI

Are there still opportunities to enroll in this clinical research endeavor?

"Clinicaltrials.gov indicates that this medical study, which began recruiting on January 1st 2023 and last updated its records on September 21st 2022 is not presently searching for participants. However, there are currently 1504 other clinical trials actively seeking candidates at the moment."

Answered by AI

Is it possible for me to be a participant in this trial?

"This research seeks to recruit 15 individuals, aged 21-64, who have suffered moral injury and fulfill the following requirements: no antidepressant treatment history prior to enrollment; minimal risk of suicidal behaviour as judged by the study clinicians; veteran status within the US military; high school education or equivalent; current DSM-5 diagnosis of Post-Traumatic Stress Disorder (PTSD); CAPS-5 total severity score ≥35 at baseline assessment point; medically stable condition; limited lifetime experience with hallucinogens; and general medical health."

Answered by AI

To what extent is Psilocybin-assisted therapy hazardous for individuals?

"Considering the current dataset, our team at Power gave Psilocybin-assisted therapy a score of 2 out of 3. This is due to Phase 2 trial data which suggests that there are some safety measures in place but no efficacy evidence yet available."

Answered by AI

Who else is applying?

What state do they live in?
South Carolina
Florida
Other
Ohio
How old are they?
18 - 65
What site did they apply to?
Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
2
1
3+
0

What questions have other patients asked about this trial?

How long would I actually have to be in Ohio? Could any of the screening or follow up be virtual?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

I want to explore what psilocybin can do for my PTSD. Looking for treatment to help me get back to my normal life again. I’m not a veteran.
PatientReceived 2+ prior treatments
I have been seeking treatments to help treat my PTSD symptoms and am curious to potentially try psilocybin to help with that.
PatientReceived no prior treatments
I have watched YouTube channels where these former Military members who have seen combat like I have are reaching out and having success with these unconventional treatment methods and I felt exactly like these other Soldiers. I kept hearing positive results and I want to see if it cab work for me as well.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Email
Average response time
  • < 2 Days
Most responsive sites:
  1. Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center: < 48 hours
~1 spots leftby Jan 2024